×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
24811 views
La SFCO vous propose un cycle de formation sur le cancer de l’ovaire en 3 Webinars.
 
On vous propose avec des sessions de 90 minutes, de faire le point sur :
  • deux techniques chirurgicales en vidéo
  • l’importance de la recherche de la mutation BRCA en particulier l’impact thérapeutique a l’ère des inhibiteurs de PARP
  • la préhabilitation et la réhabilitation précoce
  • un point d’actualité sur une publication récente
Nous vous donnons RDV pour le premier Webinar en direct de Nantes le vendredi 14 Décembre à 12h30 !

Programme

12:30 Introduction
 
12:35
Charlotte Bourgin – Cécile Loaec 
 
12:50
Carlos Martínez Gómez
 
13:05
Cancer de l’ovaire et BRCA : Comprendre le mécanisme des mutations BRCA et leur impact clinique
Thibaut de la Motte Rouge
 
13:20
Préhabiliation avant chirurgie abdominale majeure
Florence Boiffard
 
13:35
Point d’actu : LION
Fabrice Lecuru
 
13:50 Conclusion

 

Audience

  •  Chirurgiens oncologiques et oncologues francophones
Shooting date : 2018-12-14
Last update : 2021-07-08

Cancer de l’ovaire : Cycle de formation en 3 Webinars

La SFCO vous propose un cycle de formation sur le cancer de l’ovaire en 3 Webinars.   On vous propose avec des sessions de 90 minutes, de faire le point sur : deux techni...

Share
5 comments
Join the Discussion
See previous comments (1)
  • juan jose T. Excellente video Carlos !

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • nassir H. excellent session

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Franck R.

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        • Bourgin T. Bravo charlotte

            Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
            Your browser doesn't have Flash, Silverlight or HTML5 support.


          • sarhane H. Bonjour,depuis peu de temps , je n'arrive pas à lire les vidéos pourtant je suis inscrit!
            Merci de bien vouloir m'aider à résoudre ce problème.
            Cordialement

              Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
              Your browser doesn't have Flash, Silverlight or HTML5 support.


            Suggestions

            Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
            Honolulu : Tuesday, September 5th 2023 from 07:30am to 09am (GMT+2)
            San Francisco : Tuesday, September 5th 2023 from 10:30am to 12pm (GMT+2)
            New York : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
            Buenos Aires : Tuesday, September 5th 2023 from 02:30pm to 04pm (GMT+2)
            Reykjavik : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
            London / Dublin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
            Paris / Berlin : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
            Istanbul : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
            Moscou / Dubaï : Tuesday, September 5th 2023 from 09:30pm to 11pm (GMT+2)
            Bangkok : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
            Shanghai : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
            Tokyo : Wednesday, September 6th 2023 from 02:30am to 04am (GMT+2)
            Sydney : Wednesday, September 6th 2023 from 04:30am to 06am (GMT+2)
            Wellington : Wednesday, September 6th 2023 from 06:30am to 08am (GMT+2)

            Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

            Cycle d'enseignement sur le cancer de l'ovaire - Première session

            Share
            Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
            Honolulu : Wednesday, January 31st 2024 from 07am to 08:30am (GMT+1)
            San Francisco : Wednesday, January 31st 2024 from 09am to 10:30am (GMT+1)
            New York : Wednesday, January 31st 2024 from 12pm to 01:30pm (GMT+1)
            Buenos Aires : Wednesday, January 31st 2024 from 02pm to 03:30pm (GMT+1)
            London / Dublin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
            Paris / Berlin : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
            Istanbul : Wednesday, January 31st 2024 from 07pm to 08:30pm (GMT+1)
            Moscou / Dubaï : Wednesday, January 31st 2024 from 09pm to 10:30pm (GMT+1)
            Bangkok : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
            Shanghai : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
            Tokyo : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
            Sydney : Thursday, February 1st 2024 from 03am to 04:30am (GMT+1)
            Wellington : Thursday, February 1st 2024 from 05am to 06:30am (GMT+1)

            KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...

            Share
            Scroll Up